Stay updated on CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial

Sign up to get notified when there's something new on the CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-05-05T15:05:01.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.7%
    Check dated 2025-04-28T08:30:31.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed information about the Managed Access Program (MAP) for CTL019 treatment in acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL), while a new revision number has been added.
    Difference
    10%
    Check dated 2025-04-21T02:12:57.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-04-13T18:44:55.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.5%
    Check dated 2025-04-06T14:28:51.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-03-30T09:55:34.000Z thumbnail image

Stay in the know with updates to CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial page.